Drug Target Review2023-12-05T12:00:47
Carboxylic nanodiamonds could be a therapeutic agent for cancer, as melanoma cells treated with them showed little to no metastasis.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2026-05-05T13:24:00
Sponsored by HUB Organoids
2025-05-08T09:00:00
Contributor Ning Ren
2026-06-15T11:00:00
Sponsored by Miltenyi Biotec
2023-04-12T15:28:08
Sponsored by nanoComposix
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud